{"content":"<li class=\"n-box-item date-title\" data-end=\"1490327999\" data-start=\"1490241600\" data-txt=\"Sunday, December 22, 2019\">Thursday, March 23, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3253223\" data-ts=\"1490311779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLCM\" target=\"_blank\">BLCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253223-bellicum-pharmaceuticals-slipping-after-pricing-5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellicum Pharmaceuticals slipping after pricing 5M-share offering</a></h4><ul>   <li>Bellicum Pharmaceuticals (<a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals'>BLCM</a> <font color='red'>-10.2%</font>) tumbled today following news yesterday of its <a href=\"https://seekingalpha.com/news/3252835-bellicum-pharma-launches-5m-share-equity-offering-shares-slip-3-percent-hours\" target=\"_blank\">5M-share equity offering</a>, and is <font color='red'>off another 1.6%</font> after hours on news it's <a href=\"https://seekingalpha.com/pr/16780220-bellicum-pharmaceuticals-announces-pricing-public-offering-common-stock\" target=\"_blank\">priced that offering</a>.</li>    <li>The company has priced the sale at $12/share. The stock price fell to $12.90 in regular hours, from yesterday's close of $14.37, and is quoting at $12.69 in postmarket action.</li>    <li>The offering is expected to close next Wednesday; Citigroup and Jefferies are lead book-running managers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253223\" data-linked=\"Bellicum Pharmaceuticals slipping after pricing 5M-share offering\" data-tweet=\"$BLCM - Bellicum Pharmaceuticals slipping after pricing 5M-share offering https://seekingalpha.com/news/3253223-bellicum-pharmaceuticals-slipping-after-pricing-5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3253223-bellicum-pharmaceuticals-slipping-after-pricing-5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253218\" data-ts=\"1490310452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253218-jd-complus-2_3-pac-crest-launches-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com +2.3% as Pac Crest launches at Outperform</a></h4><ul>   <li>JD.com (<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a> <font color='green'>+2.3%</font>) rose today on bullish sentiment from Pacific Crest, which launched shares at Outperform with an eye toward <a href=\"http://www.investors.com/news/technology/alibaba-jd-com-get-bullish-coverage-on-e-commerce-strength-in-china/\" target=\"_blank\">Chinese strength in e-commerce</a>.</li>    <li>Pac Crest also <a href=\"https://seekingalpha.com/news/3253207-pacific-crest-securities-initiates-alibaba-overweight\" target=\"_blank\">launched Alibaba at Outperform</a> today.</li>    <li>JD.com benefits from its image for authentic products (in a market torn by charges of counterfeiting) as well as logistics strength, says analyst Hans Cheng.</li>    <li>The company said earlier this month it would <a href=\"https://seekingalpha.com/news/3248284-jd-com-freeing-finance-business-fight-growing-sector\" target=\"_blank\">spin off its finance business</a> for $2.1B, creating a better competitive front to Alibaba's Ant Financial, a positive according to Cheng: \"We see sustainable profitability around the corner driven by margin expansion and an anticipated JD Finance spin-off.\"</li>    <li>He has a price target of $40, implying 28% upside in shares from today's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253218\" data-linked=\"JD.com +2.3% as Pac Crest launches at Outperform\" data-tweet=\"$JD - JD.com +2.3% as Pac Crest launches at Outperform https://seekingalpha.com/news/3253218-jd-complus-2_3-pac-crest-launches-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3253218-jd-complus-2_3-pac-crest-launches-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253211\" data-ts=\"1490306416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253211-western-digital-seagate-gain-after-hours-post-micron-reporting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital, Seagate gain after hours post-Micron reporting</a></h4><ul><li>Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>)&nbsp;<font color='green'>+3.2%</font>, Seagate Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>)&nbsp;<font color='green'>+1.15%</font>.</li><li>Earlier (March 23, 2017): <a href=\"https://seekingalpha.com/news/3253191-micron-technology-plus-9-percent-q3-2017-outlook-substantial\" target=\"_blank\">Micron Technology +9%; Q3 2017 outlook substantial</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3253211\" data-linked=\"Western Digital, Seagate gain after hours post-Micron reporting\" data-tweet=\"$WDC $WDC $STX - Western Digital, Seagate gain after hours post-Micron reporting https://seekingalpha.com/news/3253211-western-digital-seagate-gain-after-hours-post-micron-reporting?source=tweet\" data-url=\"https://seekingalpha.com/news/3253211-western-digital-seagate-gain-after-hours-post-micron-reporting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253209\" data-ts=\"1490304943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253209-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+10.1%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+9.4%</font>. <a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='green'>+6.0%</font>. <a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color='green'>+3.0%</font>. <a href='https://seekingalpha.com/symbol/GLOG' title='GasLog'>GLOG</a> <font color='green'>+3.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color='red'>-11.5%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-9.5%</font>. <a href='https://seekingalpha.com/symbol/MTW' title='Manitowoc Company, Inc.'>MTW</a> <font color='red'>-4.8%</font>. <a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a> <font color='red'>-2.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253209\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MU $HTGM $QTNT - After Hours Gainers / Losers https://seekingalpha.com/news/3253209-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3253209-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253199\" data-ts=\"1490301693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRS\" target=\"_blank\">ARRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253199-arrisplus-3_9-updates-guidance-for-2017-long-term\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arris +3.9% as it updates guidance for 2017, long term</a></h4><ul>   <li>While the market as a whole took a <a href=\"https://seekingalpha.com/news/3253145-stocks-give-gains-turn-modestly-negative-health-bill-delay\" target=\"_blank\">turn for the worse</a> amid a congressional delay in healthcare bill voting, Arris (<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a> <font color='green'>+3.9%</font>) built strength into the afternoon after an event where it provided updated guidance.</li>    <li>Citing a \"<a href=\"https://seekingalpha.com/filing/3472006\" target=\"_blank\">strong finish to 2016</a>\" along with \"capital pull-in creating a soft first quarter 2017,\" the company says Q1 will end up at the low end of guidance. But it now expects non-GAAP revenues for the full year of $6.615B-$6.83B (vs. consensus expectation for $6.7B).</li>    <li>It's also forecasting 2017 non-GAAP EPS of $2.40-$2.60, in line with consensus for $2.51. GAAP EPS is forecast to $0.61-$0.81 vs. analyst expectations for $0.60.</li>    <li>For beyond 2017, Arris says it's well positioned in the market with industry spending coming on such initiatives as DOCSIS 3.1 deployments (scaling up in the second half), multi-year fiber deep projects and advanced home networking, among others. It also cites major growth opportunities from the Ruckus/Brocade acquisition.</li>    <li>In the long term, it's expecting the service provider CPE business will remain steady and the Networks business growing in mid-single digits, with the Ruckus Wireless and Brocade Switching business growing 5-10% a year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253199\" data-linked=\"Arris +3.9% as it updates guidance for 2017, long term\" data-tweet=\"$ARRS - Arris +3.9% as it updates guidance for 2017, long term https://seekingalpha.com/news/3253199-arrisplus-3_9-updates-guidance-for-2017-long-term?source=tweet\" data-url=\"https://seekingalpha.com/news/3253199-arrisplus-3_9-updates-guidance-for-2017-long-term\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253191\" data-ts=\"1490301098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253191-micron-technologyplus-9-q3-2017-outlook-substantial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron Technology +9%; Q3 2017 outlook substantial</a></h4><ul><li><strong><a href=\"https://seekingalpha.com/news/3253165-micron-technology-beats-0_05-revenue-line\" target=\"_blank\">Q2 2017 results</a></strong> &ndash; revenue $4.65B (+58.7% Y/Y, in line), EPS $0.90 (<font color='green'>$0.05 above estimates</font>), gross margin 38.5% (vs. 26% Q/Q, 20.4% Y/Y), net income $1.03B (vs. $335M Q/Q, $12M Y/Y), DRAM average selling prices +21% Q/Q, trade NAND sales volumes +18% Q/Q, capital expenditures investments $1.17B, cash, marketable investments and restricted cash $4.58B</li><li><strong><a href=\"http://investors.micron.com/secfiling.cfm?filingID=723125-17-31&amp;CIK=723125\" target=\"_blank\">Q3 2017 projections</a></strong> &ndash; revenue $5.2B-$5.6B (consensus $4.7B), EPS $1.43-$1.57 (<a href=\"https://finance.yahoo.com/quote/MU/analysts?p=MU\" target=\"_blank\">consensus $0.89</a>), gross margin 44%-48%, operating expenses $560M-$610M, operating income $1.8B-$2B</li><li>Micron Technology CEO&nbsp;Mark Durcan spotlights strong demand and limited supply for NAND and DRAM, as well as advancements the company's made regarding cost reductions.</li><li><strong>After hours</strong> &ndash; (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) $28.85</li><li><a href=\"https://seekingalpha.com/pr/16780061-micron-technology-inc-reports-results-second-quarter-fiscal-2017\" target=\"_blank\">Press release</a> / <a href=\"http://edge.media-server.com/m/p/vuwo88xr\" target=\"_blank\">conference call</a> / <a href=\"https://seekingalpha.com/filing/3472359\" target=\"_blank\">8-K</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3253191\" data-linked=\"Micron Technology +9%; Q3 2017 outlook substantial\" data-tweet=\"$MU - Micron Technology +9%; Q3 2017 outlook substantial https://seekingalpha.com/news/3253191-micron-technologyplus-9-q3-2017-outlook-substantial?source=tweet\" data-url=\"https://seekingalpha.com/news/3253191-micron-technologyplus-9-q3-2017-outlook-substantial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253190\" data-ts=\"1490300910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RXDX\" target=\"_blank\">RXDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253190-ignyta-to-explore-strategic-options-regarding-cancer-candidate-taladegib-shares-up-7-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ignyta to explore strategic options regarding cancer candidate taladegib; shares up 7% after hours</a></h4><ul><li>Ignyta (NASDAQ:<a href='https://seekingalpha.com/symbol/RXDX' title='Ignyta, Inc.'>RXDX</a>) perks up&nbsp;<font color='green'>7%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/16780038-ignyta-announces-exploration-strategic-options-taladegib-enabled-amendment-taladegib-license\" target=\"_blank\">announcement </a>that it has amended its 2015 license agreement with Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) allowing it to pursue strategic alternatives (i.e, the best development path) for small molecule taladegib, in development for the treatment of a range of cancers.</li><li>Specifically, the company will explore/assess the best development avenues for single-agent oral taladegib and the topical formulation via sub-licensing or selling the franchise to dermatology-focused companies with an interest in superficial, nodular and advanced basal cell carcinoma. It adds that unnamed firms have already expressed interest in the assets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253190\" data-linked=\"Ignyta to explore strategic options regarding cancer candidate taladegib; shares up 7% after hours\" data-tweet=\"$RXDX $RXDX $LLY - Ignyta to explore strategic options regarding cancer candidate taladegib; shares up 7% after hours https://seekingalpha.com/news/3253190-ignyta-to-explore-strategic-options-regarding-cancer-candidate-taladegib-shares-up-7-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3253190-ignyta-to-explore-strategic-options-regarding-cancer-candidate-taladegib-shares-up-7-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253187\" data-ts=\"1490300448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253187-weak-profit-guidance-sends-gamestop-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak profit guidance sends GameStop lower</a></h4><ul> <li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) reports comparable sale fell 16.3% in <a href=\"https://seekingalpha.com/pr/16780076-gamestop-reports-sales-earnings-fiscal-2016-provides-2017-outlook\" target=\"_blank\">Q4</a> amid what the company calls \"weak\" video game demand.</li> <li>Comparable sales were down 20% in the U.S. during the quarter.</li> <li>New hardware sales declined 29% and new software sales fell off 19%. Pre-owned sales dropped 6.7% to $680.6M to account for 22.3% of all sales vs. 20.7% last year.</li> <li>A bright spot for GameStop in Q4 was the collectibles category, with sales up 28% Y/Y to $212M.</li> <li>GameStop expects FY17 revenue of -2% to +2% and FY18 EPS of $3.10 to $3.40 vs. $3.72 consensus. \"As we continue our transformation plan, we will also be focused on managing SG&amp;A spend, rationalizing our global store portfolio, and maximizing free cash flow generation to drive shareholder value,\" says CEO Paul Raines.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3253166-gamestop-beats-0_09-misses-revenue\" target=\"_blank\">GameStop beats by $0.09, misses on revenue</a> (March 23)</li> <li>Shares of GameStop are <font color='red'>down 7.97%</font> AH to $22.05.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253187\" data-linked=\"Weak profit guidance sends GameStop lower\" data-tweet=\"$GME - Weak profit guidance sends GameStop lower https://seekingalpha.com/news/3253187-weak-profit-guidance-sends-gamestop-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3253187-weak-profit-guidance-sends-gamestop-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253186\" data-ts=\"1490300280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STWD\" target=\"_blank\">STWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253186-starwood-propertyminus-2-on-convertible-note-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starwood Property -2% on convertible note offering</a></h4><ul><li>Starwood Property (NYSE:<a href='https://seekingalpha.com/symbol/STWD' title='Starwood Property Trust, Inc.'>STWD</a>) is <a href=\"https://seekingalpha.com/pr/16780092-starwood-property-trust-announces-public-offering-convertible-notes\" target=\"_blank\">selling $200M of </a>convertible notes due 2023. Proceeds will be used over time to purchase outstanding 4.55% convertible notes due next year.</li><li>Shares&nbsp;<font color='red'>-1.95%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3253186\" data-linked=\"Starwood Property -2% on convertible note offering\" data-tweet=\"$STWD - Starwood Property -2% on convertible note offering https://seekingalpha.com/news/3253186-starwood-propertyminus-2-on-convertible-note-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3253186-starwood-propertyminus-2-on-convertible-note-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253184\" data-ts=\"1490300189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOP\" target=\"_blank\">GLOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253184-gaslog-partners-to-buy-lng-carrier-from-gaslog-ltd-for-219m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GasLog Partners to buy LNG carrier from GasLog Ltd. for $219M</a></h4><ul>     <li>GasLog Partners (NYSE:<a href='https://seekingalpha.com/symbol/GLOP' title='GasLog Partners LP'>GLOP</a>) <a href=\"https://seekingalpha.com/pr/16780080-gaslog-partners-lp-announces-acquisition-gaslog-greece-gaslog-ltd-219-million\" target=\"_blank\">agrees to buy</a> the GasLog Greece liquefied natural gas carrier from GasLog Ltd. (NYSE:<a href='https://seekingalpha.com/symbol/GLOG' title='GasLog'>GLOG</a>) for $219M.</li><li>GLOP says the deal supports its guidance to grow unitholder distributions at a  10%-15% compound annual rate, and would result in an  annualized distribution of $2.09 per unit or  higher by Q4 2017.</li>     <li>The vessel is currently on a long-term time charter with a Royal Dutch Shell subsidiary through March 2026.</li><li>GLOP&nbsp;<font color='green'>+1.6%</font>, GLOG <font color='green'>+3%</font>&nbsp;AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253184\" data-linked=\"GasLog Partners to buy LNG carrier from GasLog Ltd. for $219M\" data-tweet=\"$GLOP $GLOP $GLOG - GasLog Partners to buy LNG carrier from GasLog Ltd. for $219M https://seekingalpha.com/news/3253184-gaslog-partners-to-buy-lng-carrier-from-gaslog-ltd-for-219m?source=tweet\" data-url=\"https://seekingalpha.com/news/3253184-gaslog-partners-to-buy-lng-carrier-from-gaslog-ltd-for-219m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253173\" data-ts=\"1490299806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253173-sportsmans-warehouse-drops-sharply-after-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse drops sharply after earnings miss</a></h4><ul> <li>Sportsman's Warehouse Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) reports same-store sales fell 5.2% in <a href=\"https://seekingalpha.com/pr/16780052-sportsmans-warehouse-holdings-inc-announces-fourth-quarter-fiscal-year-2016-financial-results\" target=\"_blank\">FQ4</a>.</li> <li>The company says the anniversity of the San Bernardino tragedy and a strong level of executive orders a year ago created a difficult comparison.</li> <li>Gross profit fell 40 bps to 33.6% during the quarter. Net income as a percentage of sales decreased 70 bps to 4.8%.</li> <li>Sportsman's Warehouse expects to open 12 stores this fiscal year. Guidance is for revenue of $150M to $155M and EPS of -$.06 to -$0.08.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3253159-sportsmans-warehouse-misses-0_02-misses-revenue\" target=\"_blank\">Sportsmans Warehouse misses by $0.02, misses on revenue</a> (March 23)</li> <li>Shares of SPWH are <font color='red'>down 16.30%</font> in AH trading after jumping 7.94% before the bell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253173\" data-linked=\"Sportsman&#39;s Warehouse drops sharply after earnings miss\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse drops sharply after earnings miss https://seekingalpha.com/news/3253173-sportsmans-warehouse-drops-sharply-after-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3253173-sportsmans-warehouse-drops-sharply-after-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253165\" data-ts=\"1490299607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253165-micron-technology-beats-0_05-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron Technology beats by $0.05,  revenue in-line</a></h4><ul><li>Micron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>): FQ2 EPS of $0.90 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $4.65B (+58.7% Y/Y) in-line.</li><li>Shares <font color='green'>+3.9%</font>.</li><li><a href='https://seekingalpha.com/pr/16780061-micron-technology-inc-reports-results-second-quarter-fiscal-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3253165\" data-linked=\"Micron Technology beats by $0.05,  revenue in-line\" data-tweet=\"$MU - Micron Technology beats by $0.05, revenue in-line https://seekingalpha.com/news/3253165-micron-technology-beats-0_05-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3253165-micron-technology-beats-0_05-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>123&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253148\" data-ts=\"1490298374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNSL\" target=\"_blank\">CNSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253148-consolidated-fairpoint-communications-rise-merger-vote-on-track\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consolidated, FairPoint Communications rise with merger vote on track</a></h4><ul>   <li>Consolidated Communications (<a href='https://seekingalpha.com/symbol/CNSL' title='Consolidated Communications Holdings, Inc.'>CNSL</a> <font color='green'>+1.4%</font>) and FairPoint Communications (<a href='https://seekingalpha.com/symbol/FRP' title='FairPoint Communications, Inc.'>FRP</a> <font color='green'>+1.9%</font>) have seen gains today after winning the dismissal of a suit over stock issuance tied to the two companies' planned merger.</li>    <li>A preliminary injunction issued in the case of Vento v. Currey et al. threatened to delay a special meeting of Consolidated stockholders set for next Tuesday.</li>    <li>In its <a href=\"https://seekingalpha.com/filing/3471791\" target=\"_blank\">filing</a>, Consolidated noted it supplemented disclosures to add additional information on fees due to be paid to adviser Morgan Stanley, and says the injunction was vacated and the lawsuit dismissed.</li>    <li>The special meeting on march 28 will go on as scheduled, the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253148\" data-linked=\"Consolidated, FairPoint Communications rise with merger vote on track\" data-tweet=\"$CNSL $CNSL $FRP - Consolidated, FairPoint Communications rise with merger vote on track https://seekingalpha.com/news/3253148-consolidated-fairpoint-communications-rise-merger-vote-on-track?source=tweet\" data-url=\"https://seekingalpha.com/news/3253148-consolidated-fairpoint-communications-rise-merger-vote-on-track\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253147\" data-ts=\"1490298262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253147-credit-suisse-negative-on-dollar-general\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse negative on Dollar General</a></h4><ul> <li>Credit Suisse issues a harsh outlook on Dollar General (NYSE:<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a>).</li> <li>\"DG&rsquo;s long-term growth algorithm looks unachievable, as increasing competition and rising cost pressures should weigh on earnings for some time,\" writes analyst Edward Kelly.</li> <li>\"While Q4 beat low expectations, the update highlighted underlying concerns related to sales momentum, margin sustainability, and the logic behind ramping openings to 1,000 stores per year. We believe DG will ultimately be forced to reset expectations and disappoint a street consensus that has assumed a reacceleration to 10% annual growth after a flat 2017,\" he adds.</li><li>CS lowers the retailer to an Underperform rating and lowers its price target to $62.</li> <li>Last week, Dollar General said that it&nbsp;<a href=\"https://seekingalpha.com/pr/16772926-dollar-general-reports-fourth-quarter-fiscal-2016-financial-results-company-provides\" target=\"_blank\">expects</a> same-store sales to be up 0% to 2% this year.</li> <li>On a strong day for the retail sector, shares of Dollar General are <font color='red'>down 2.50%</font> to $68.92.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253147\" data-linked=\"Credit Suisse negative on Dollar General\" data-tweet=\"$DG - Credit Suisse negative on Dollar General https://seekingalpha.com/news/3253147-credit-suisse-negative-on-dollar-general?source=tweet\" data-url=\"https://seekingalpha.com/news/3253147-credit-suisse-negative-on-dollar-general\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253141\" data-ts=\"1490297382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253141-american-airlines-rallies-after-positive-take-from-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines rallies after positive take from Stifel</a></h4><ul> <li>American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a>) is <font color='green'>up 2.70%</font> after Stifel Nicolaus adds the airline company to its Select List of favored stocks.</li> <li>The Stifel team is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/03/23/why-american-airlines-is-soaring/\" target=\"_blank\">convinced</a> that investors are underestimating the power of the American frequent flier program to generate revenue. The frequent flier revenue stream could total $2.7B in 2018, estimates the firm. Perhaps just as important, FF revenue is \"immune\" from added capacity or weaker pricing, advises Stifel.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3253141\" data-linked=\"American Airlines rallies after positive take from Stifel\" data-tweet=\"$AAL - American Airlines rallies after positive take from Stifel https://seekingalpha.com/news/3253141-american-airlines-rallies-after-positive-take-from-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3253141-american-airlines-rallies-after-positive-take-from-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253137\" data-ts=\"1490296119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SC\" target=\"_blank\">SC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253137-santander-consumerminus-3-after-fed-sanctions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Santander Consumer -3% after Fed sanctions</a></h4><ul>     <li>At issue <a href=\"https://www.federalreserve.gov/newsevents/pressreleases/files/enf20170323a1.pdf\" target=\"_blank\">are \"deficiencies\" in</a> consumer compliance that the company had been ordered to fix in 2015.</li><li>The action <a href=\"http://thefly.com/permalinks/entry.php/id2524493/SC-Santander-Consumer-analyst-commentary-at-Wells-Fargo\" target=\"_blank\">raises dividend uncertainty</a> for Santander (<a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a> <font color='red'>-3%</font>), says Wells Fargo's Joel Houck, who previously saw the chance of an H2 payout as a potential catalyst for the stock.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253137\" data-linked=\"Santander Consumer -3% after Fed sanctions\" data-tweet=\"$SC - Santander Consumer -3% after Fed sanctions https://seekingalpha.com/news/3253137-santander-consumerminus-3-after-fed-sanctions?source=tweet\" data-url=\"https://seekingalpha.com/news/3253137-santander-consumerminus-3-after-fed-sanctions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253134\" data-ts=\"1490295622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253134-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OIBR.C' title='Oi S.A. ADR'>OIBR.C</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VRNS' title='Varonis Systems Inc'>VRNS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EGAN' title='eGain Communications Corp.'>EGAN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CPSH' title='CPS Technologies Corp.'>CPSH</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PRKR' title='ParkerVision, Inc.'>OTC:PRKR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253134\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$OIBR.C $AXTI $VRNS - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3253134-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3253134-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253133\" data-ts=\"1490295454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWDP\" target=\"_blank\">DWDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253133-reuters-eu-regulators-may-soon-ok-dow-dupont-chemchina-syngenta-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: EU regulators may soon OK Dow-DuPont, ChemChina-Syngenta deals</a></h4><ul>     <li>European Union antitrust regulators are <a href=\"http://www.reuters.com/article/us-eu-m-a-dow-chemchina-idUSKBN16U2N1\" target=\"_blank\">set to clear the merger</a> of Dow Chemical (DOW <font color='green'>+1.7%</font>) and DuPont (DD <font color='green'>+1.7%</font>) as well as ChemChina's takeover bid for Syngenta (<a href='https://seekingalpha.com/symbol/SYT' title='Syngenta AG'>SYT</a> <font color='green'>+1.2%</font>), Reuters reports.</li>     <li>The European Commission reportedly could announce its approvals for both companies at the same time either on Monday or Tuesday; such a joint merger announcement would be rare but it could make sense in this case since both companies are in the agrochemicals sector.</li>     <li>The EU antitrust enforcer has set an April 4 deadline for the Dow-DuPont deal, and April 12 for the ChemChina-Syngenta deal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253133\" data-linked=\"Reuters: EU regulators may soon OK Dow-DuPont, ChemChina-Syngenta deals\" data-tweet=\"$DWDP $DD $SYT - Reuters: EU regulators may soon OK Dow-DuPont, ChemChina-Syngenta deals https://seekingalpha.com/news/3253133-reuters-eu-regulators-may-soon-ok-dow-dupont-chemchina-syngenta-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3253133-reuters-eu-regulators-may-soon-ok-dow-dupont-chemchina-syngenta-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253132\" data-ts=\"1490294716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EEP\" target=\"_blank\">EEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253132-enbridge-energy-partnersplus-3_5-morgan-stanley-rates-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enbridge Energy Partners +3.5% as Morgan Stanley rates Overweight</a></h4><ul><li>Enbridge Energy Partners (<a href='https://seekingalpha.com/symbol/EEP' title='Enbridge Energy Partners L.P.'>EEP</a> <font color='green'>+3.6%</font>) is higher after Morgan Stanley awards it an <a href=\"http://blogs.barrons.com/incomeinvesting/2017/03/23/enbridge-rises-as-morgan-stanley-says-to-overweight-mlp/?mod=BOL_hp_blog_ii\" target=\"_blank\">Overweight rating</a>, even though a distribution cut of as much as 40% is likely when the MLP eventually completes its strategic review.</li><li>Stanley sees a compelling valuation after the units have dropped ~30% since EEP updated investors on its plans in January, with more upside potential depending on how the distribution cut is implemented by parent company Enbridge (<a href='https://seekingalpha.com/symbol/ENB' title='Enbridge Inc.'>ENB</a> <font color='red'>-0.7%</font>).</li><li>The firm thinks the strategic review could help EEP if ENB is further supportive by, for example, offering additional and possibly over-equitized drops at attractive multiples with the take-back of units, revamping joint funding agreements, or eliminating the modest incentive distribution rights burden.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253132\" data-linked=\"Enbridge Energy Partners +3.5% as Morgan Stanley rates Overweight\" data-tweet=\"$EEP $EEP $ENB - Enbridge Energy Partners +3.5% as Morgan Stanley rates Overweight https://seekingalpha.com/news/3253132-enbridge-energy-partnersplus-3_5-morgan-stanley-rates-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3253132-enbridge-energy-partnersplus-3_5-morgan-stanley-rates-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253128\" data-ts=\"1490294029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRIP\" target=\"_blank\">TRIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253128-tripadvisor-jumps-amid-buyout-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tripadvisor jumps amid buyout chatter</a></h4><ul> <li>Tripadvisor (<a href='https://seekingalpha.com/symbol/TRIP' title='TripAdvisor Inc.'>TRIP</a> <font color='green'>+2.6%</font>) rallies on trader chatter that Priceline could be interested in a takeover. The TRIP-PCLN scenario has been bandied about a few times in the past without a deal being struck.</li> <li>Shares of Tripadvisor peaked today at $42.61 vs. a 52-week range of $40.45 to $71.69.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3253128\" data-linked=\"Tripadvisor jumps amid buyout chatter\" data-tweet=\"$TRIP - Tripadvisor jumps amid buyout chatter https://seekingalpha.com/news/3253128-tripadvisor-jumps-amid-buyout-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3253128-tripadvisor-jumps-amid-buyout-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253114\" data-ts=\"1490292056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253114-energy-material-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Material - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CNXC' title='CNX Coal Resources'>CNXC</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/WG' title='Willbros Group, Inc.'>WG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OEC' title='Orion Engineered Carbons'>OEC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ASM' title='Avino Silver & Gold Mines Ltd'>ASM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CDEV' title='Centennial Resource Development'>CDEV</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253114\" data-linked=\"Energy/Material - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CNXC $ECR-OLD $WLB - Energy/Material - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3253114-energy-material-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3253114-energy-material-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253108\" data-ts=\"1490290738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RACE\" target=\"_blank\">RACE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253108-all-time-high-for-ferrari-in-milan-and-new-york\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">All-time high for Ferrari in Milan and New York</a></h4><ul> <li>Ferrari (<a href='https://seekingalpha.com/symbol/RACE' title='Ferrari N.V.'>RACE</a> <font color='green'>+4%</font>) rallies to a new all-time high in New York after Citi boosts the automaker to Buy from Neutral.</li> <li>The investment firm thinks Ferrari has more room to increase prices and could boost volume by as much as 100% in a decade.</li> <li>Citi</a> on Ferrari: \"The allure of the Ferrari brand makes them behave like a Giffen good, and we don&rsquo;t foresee any risk to their exclusive appeal. Since 1997 Porsche volumes have grown sevenfold, but pricing of its core 911 has improved relative to mass market models. Over the same period Ferrari volumes have grown twofold, while the number of wealthy individuals has also doubled. To our minds Ferrari can grow volumes considerably with limited risk.\"</li><li>Ferrari closed <font color='green'>up 4.35%</font> in Milan at its all-time high of &euro;65.90</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253108\" data-linked=\"All-time high for Ferrari in Milan and New York\" data-tweet=\"$RACE - All-time high for Ferrari in Milan and New York https://seekingalpha.com/news/3253108-all-time-high-for-ferrari-in-milan-and-new-york?source=tweet\" data-url=\"https://seekingalpha.com/news/3253108-all-time-high-for-ferrari-in-milan-and-new-york\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253087\" data-ts=\"1490290429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253087-valeritas-stumbles-out-of-gate-shares-down-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas stumbles out of the gate, shares down 25%</a></h4><ul><li>IPO Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>)&nbsp;is having rough first day. Shares are down from from the offer price of $10 which was reduced 33% from the midpoint of its original target of $14 - 16.</li><li>An earlier data snafu showed shares up almost 135%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252501-valeritas-readies-downsized-ipo\" target=\"_blank\">Valeritas readies downsized IPO</a> (March 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3253087\" data-linked=\"Valeritas stumbles out of the gate, shares down 25%\" data-tweet=\"$VLRX - Valeritas stumbles out of the gate, shares down 25% https://seekingalpha.com/news/3253087-valeritas-stumbles-out-of-gate-shares-down-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3253087-valeritas-stumbles-out-of-gate-shares-down-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253105\" data-ts=\"1490290076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253105-sportsmans-warehouse-rallies-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse rallies into earnings</a></h4><ul> <li>Sportsman's Warehouse Holdings (<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+6.2%</font>) breaks higher ahead of the company's earning report due out after the bell.</li> <li>Analysts expect the company to report revenue of $229M and EPS of $0.27.</li> <li>Even with today's bump, shares of Sportsman's Warehouse are down 47% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253105\" data-linked=\"Sportsman&#39;s Warehouse rallies into earnings\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse rallies into earnings https://seekingalpha.com/news/3253105-sportsmans-warehouse-rallies-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3253105-sportsmans-warehouse-rallies-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253097\" data-ts=\"1490288362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SITC\" target=\"_blank\">SITC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253097-mall-and-shopping-center-reits-break-losing-string\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mall and shopping center REITs break losing string</a></h4><ul><li>The roughed-up group is a wall of green today, helped along by a UBS upgrade to Neutral from Sell for DDR (DDR <font color='green'>+2.3%</font>). Analyst Nick Yulico says the bad news for retail landlords is likely priced in at this point, and he has hopes for the new management team at DDR.</li><li>Other movers include: Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='green'>+2.3%</font>), Federal Realty (<a href='https://seekingalpha.com/symbol/FRT' title='Federal Realty Investment Trust'>FRT</a> <font color='green'>+1.8%</font>), Whitestone (<a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='green'>+2.3%</font>), Kite Realty (<a href='https://seekingalpha.com/symbol/KRG' title='Kite Realty Group Trust'>KRG</a> <font color='green'>+2.4%</font>), CBL &amp; Associates (<a href='https://seekingalpha.com/symbol/CLB' title='Core Laboratories'>CLB</a>), Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='green'>+1.9%</font>), General Growth (GGP <font color='green'>+1.9%</font>), PREIT (<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a> <font color='green'>+3.7%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252777-another-rough-session-retail-reits-keybanc-downgrades-sears-warns\" target=\"_blank\">Another rough session for retail REITs as KeyBanc downgrades, Sears warns</a> (March 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3253097\" data-linked=\"Mall and shopping center REITs break losing string\" data-tweet=\"$SITC $SITC $KIM - Mall and shopping center REITs break losing string https://seekingalpha.com/news/3253097-mall-and-shopping-center-reits-break-losing-string?source=tweet\" data-url=\"https://seekingalpha.com/news/3253097-mall-and-shopping-center-reits-break-losing-string\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253092\" data-ts=\"1490287510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253092-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+98%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/VSR' title='Versar, Inc'>VSR</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power, Inc.'>PLUG</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PENN' title='Penn National Gaming, Inc.'>PENN</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> CERU <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253092\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$HTGM $FLXN $VSR - Midday Gainers / Losers https://seekingalpha.com/news/3253092-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3253092-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253079\" data-ts=\"1490284893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253079-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SNAK' title='Inventure Foods, Inc.'>SNAK</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MLHR' title='Herman Miller, Inc.'>MLHR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BREW' title='Craft Brew Alliance Inc'>BREW</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253079\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$PVH $SPWH $SNAK - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3253079-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3253079-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253074\" data-ts=\"1490283940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253074-fda-oks-medicure-subsidiary-apicores-generic-xenazine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Medicure subsidiary Apicore&#39;s generic Xenazine</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16779238-medicure-announces-fda-approval-apicores-generic-tetrabenazine\" target=\"_blank\">approves </a>Apicore's Abbreviated New Drug Application &#40;ANDA&#41; for tetrabenazine tablets, the generic equivalent of Valeant Pharmaceuticals' (VRX <font color='green'>+2.8%</font>) <a href=\"http://www.xenazineusa.com/\" target=\"_blank\">Xenazine</a>, indicated for the treatment of involuntary movements of Huntington's disease. The product was recently launched by development partner TAGI Pharma.</li><li>Apicor is majority owned by Medicure (<a href='https://seekingalpha.com/symbol/MCUJF' title='Medicure Inc.'>OTCPK:MCUJF</a> <font color='green'>+3.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3253074\" data-linked=\"FDA OKs Medicure subsidiary Apicore&#39;s generic Xenazine\" data-tweet=\"$BHC $BHC $MCUJF - FDA OKs Medicure subsidiary Apicore&#39;s generic Xenazine https://seekingalpha.com/news/3253074-fda-oks-medicure-subsidiary-apicores-generic-xenazine?source=tweet\" data-url=\"https://seekingalpha.com/news/3253074-fda-oks-medicure-subsidiary-apicores-generic-xenazine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253070\" data-ts=\"1490282973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253070-harmony-gold-hit-wildcat-strike-south-africa-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmony Gold hit by wildcat strike at South Africa mine</a></h4><ul>     <li>Harmony Gold (<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='red'>-4.5%</font>) sinks on news of a <a href=\"https://www.moneyweb.co.za/news-fast-news/wildcat-strike-hits-harmony-golds-kusasalethu-mine/\" target=\"_blank\">wildcat strike</a> at its Kusasalethu mine in South Africa, which the company says was encouraged by the AMCU union in response to the disciplinary procedures against 40  employees following the illegal sit-in at the mine in January.</li>     <li>Kusasalethu has been a flash point for labor violence and strikes in recent years, threatening the viability of the mine and underlining the social risks of mining in South Africa.</li><li>The mine has ~4,500 employees and produced ~124K oz. of gold in FY 2016.</li><li>Separately, HMY said yesterday that it aims to <a href=\"http://www.miningweekly.com/article/harmony-plans-to-grow-output-to-15moz-outlines-acquisition-criteria-2017-03-22\" target=\"_blank\">hike its yearly gold production</a> to 1.5M oz. from the current 1.1M oz. over the next three years, as it undertakes expansions at its operations in South Africa, the rest of Africa and Papua New Guinea while also potentially acquiring low-cost, high-value assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253070\" data-linked=\"Harmony Gold hit by wildcat strike at South Africa mine\" data-tweet=\"$HMY - Harmony Gold hit by wildcat strike at South Africa mine https://seekingalpha.com/news/3253070-harmony-gold-hit-wildcat-strike-south-africa-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3253070-harmony-gold-hit-wildcat-strike-south-africa-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253069\" data-ts=\"1490282246\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNA\" target=\"_blank\">ASNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253069-retail-stocks-churn-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail stocks churn higher</a></h4><ul> <li>Strong earnings report from Five Below and PVH seem to be swaying investors in the retail sector. The two late reporters gave a deeper look at Q1 trends than some of the earlier earnings disclosers. Investors may also be factoring in the heated battle in Congress over health care reform as an indication that the border tax proposal could face an uphill climb.</li><li>Today's strong move in the U.S. follows a day in the Europe where retail names are beating out all sectors in the Stoxx Europe 600.</li> <li>Select retail gainers: Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+5.8%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+3%</font>), Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='green'>+6.2%</font>), Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+3.9%</font>), Office Depot (<a href='https://seekingalpha.com/symbol/ODP' title='Office Depot Inc.'>ODP</a> <font color='green'>+4.2%</font>), Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='green'>+4.5%</font>), Stein Mart (<a href='https://seekingalpha.com/symbol/SMRT' title='Stein Mart, Inc.'>SMRT</a> <font color='green'>+3.7%</font>), Cato (<a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='green'>+4.1%</font>) and Francesca's (<a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='green'>+3.4%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+4.2%</font>), Tuesday Morning (<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a> <font color='green'>+1.6%</font>), Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='green'>+3.3%</font>) and Boot Barn (<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='green'>+2.3%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3253035-five-plus-11-percent-organic-growth-remains-track\" target=\"_blank\">Five Below +11% as organic growth remains on track</a> (March 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252871-pvh-7-percent-beats-q4-extends-buyback\" target=\"_blank\">PVH up 7% as it beats in Q4, extends buyback</a> (March 22)</li><li>The S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is&nbsp;<font color='green'>up 1.64%</font>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3253069\" data-linked=\"Retail stocks churn higher\" data-tweet=\"$ASNA $ASNA $GPS - Retail stocks churn higher https://seekingalpha.com/news/3253069-retail-stocks-churn-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3253069-retail-stocks-churn-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253066\" data-ts=\"1490281953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253066-dea-categorizes-insys-syndros-schedule-ii-u-s-market-launch-planned-for-h2-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DEA categorizes Insys&#39; Syndros Schedule II, U.S. market launch planned for H2; shares ahead 7%</a></h4><ul><li>Insys Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+7.2%</font>) <a href=\"https://seekingalpha.com/pr/16779251-dea-schedules-insys-therapeutics-syndros-dronabinol-oral-solution-schedule-ii-drug\" target=\"_blank\">announces </a>that the DEA has issued a preliminary rule placing Syndros (dronabinol oral solution) in Schedule II of the Controlled Substances Act. Schedule II drugs are ones with a high potential for abuse (e.g., pharmaceutical narcotics, morphine, opium and codeine).</li><li>The DEA's action clears the way for the commercial launch in the U.S., pending final labeling.</li><li>The FDA approved the product in July 2016 for the treatment of anorexia-associated weight loss in AIDS patients and chemotherapy-induced nausea and vomiting in patients who failed to respond to conventional antiemetic treatments.</li><li>Syndros is a liquid formulation of the pharmaceutical cannabinoid, dronabinol, a synthetic version of tetrahydrocannabinol &#40;THC&#41;.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3191673-fda-approves-insys-therapeutics-syndros-anorexia-weight-loss-cinv-shares-ahead-21-percent\" target=\"_blank\">FDA approves Insys Therapeutics' Syndros for anorexia weight loss and CINV; shares ahead 21% premarket</a> (July 5, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3253066\" data-linked=\"DEA categorizes Insys&#39; Syndros Schedule II, U.S. market launch planned for H2; shares ahead 7%\" data-tweet=\"$INSY $INSYQ - DEA categorizes Insys&#39; Syndros Schedule II, U.S. market launch planned for H2; shares ahead 7% https://seekingalpha.com/news/3253066-dea-categorizes-insys-syndros-schedule-ii-u-s-market-launch-planned-for-h2-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3253066-dea-categorizes-insys-syndros-schedule-ii-u-s-market-launch-planned-for-h2-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253032\" data-ts=\"1490281386\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253032-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+92%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='green'>+34%</font>. SSH <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> CERU <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-13%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253032\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$HTGM $FLXN $CHFS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3253032-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3253032-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253056\" data-ts=\"1490280378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLXN\" target=\"_blank\">FLXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253056-flexion-spikes-26-on-pending-sanofi-takeover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flexion spikes 26% on pending Sanofi takeover</a></h4><ul><li>Flexion Therapeutics (<a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='green'>+26.1%</font>) jumps on almost triple normal volume on the news that Sanofi (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='green'>+0.6%</font>) will <a href=\"http://www.fiercepharma.com/pharma/sanofi-verge-1b-plus-deal-for-arthritis-focused-biotech-flexion\" target=\"_blank\">acquire </a>the Boston area-based biotech for more than $1B in cash. Sources close to the matter say Flexion's board has agreed to accept a bid in the \"mid-thirties.\"</li><li>Flexion's osteoarthritis of the knee candidate Zilretta is currently under FDA review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253056\" data-linked=\"Flexion spikes 26% on pending Sanofi takeover\" data-tweet=\"$FLXN $FLXN $SNY - Flexion spikes 26% on pending Sanofi takeover https://seekingalpha.com/news/3253056-flexion-spikes-26-on-pending-sanofi-takeover?source=tweet\" data-url=\"https://seekingalpha.com/news/3253056-flexion-spikes-26-on-pending-sanofi-takeover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253054\" data-ts=\"1490279975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253054-house-speaker-ryan-postpones-news-conference-on-ahca-vote-on-apparent-last-minute-push-for\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">House Speaker Ryan postpones news conference on AHCA vote on apparent last-minute push for votes; hospital shares rally</a></h4><ul><li>Hospital stocks perk up on investor optimism that Republicans may not have the votes in the House to pass the American Health Care Act &#40;AHCA&#41;. Speaker Paul Ryan has <a href=\"http://www.marketwatch.com/story/house-speaker-ryan-delays-news-conference-ahead-of-health-care-vote-2017-03-23\" target=\"_blank\">postponed </a>his planned 11:30 am ET news conference until 3:30 pm ET signaling that more votes may be needed for passage.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+1.4%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+3.5%</font>)(<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+3.7%</font>)(<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='green'>+2.9%</font>)(<a href='https://seekingalpha.com/symbol/SSY' title='SunLink Health Systems, Inc'>SSY</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+1.1%</font>)</li><li><strong>Update</strong>: Bloomberg reports that the Speaker has postponed the press conference a second time.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253054\" data-linked=\"House Speaker Ryan postpones news conference on AHCA vote on apparent last-minute push for votes; hospital shares rally\" data-tweet=\"$HUM $HUM $HCA - House Speaker Ryan postpones news conference on AHCA vote on apparent last-minute push for votes; hospital shares rally https://seekingalpha.com/news/3253054-house-speaker-ryan-postpones-news-conference-on-ahca-vote-on-apparent-last-minute-push-for?source=tweet\" data-url=\"https://seekingalpha.com/news/3253054-house-speaker-ryan-postpones-news-conference-on-ahca-vote-on-apparent-last-minute-push-for\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253053\" data-ts=\"1490279820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253053-cloud-peak-upgraded-fbr-peabody-s-emergence-may-boost-coal-valuations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloud Peak upgraded at FBR; Peabody\u2019s emergence may boost coal valuations</a></h4><ul>     <li>Cloud Peak Energy (<a href='https://seekingalpha.com/symbol/CLD' title='Cloud Peak Energy, Inc.'>CLD</a> <font color='green'>+2%</font>) is <a href=\"https://www.streetinsider.com/Analyst+Comments/FBR+Capital+Upgrades+Cloud+Peak+Energy+%28CLD%29+to+Market+Perform+on+Eve+of+Peabody+Emergence+from+Bankruptcy/12698385.html\" target=\"_blank\">upgraded</a> to Market Perform from Underperform with a $4 price target at FBR, which says the stock's valuation is fair compared to its outlook for the timing and extent of a potential recovery.</li>     <li>The firm says CLD management has done a fine job repositioning the company, from restructuring its export obligations  to addressing the bonding questions to issuing equity and redeeming debt; however, CLD's exposure to volatile seaborne pricing remains a key uncertainty.</li>     <li>FBR also thinks Peabody Energy&rsquo;s (BTUUQ) emergence from bankruptcy is bullish for the broader coal sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a>), as the move could attract more liquidity and long-term capital to the industry, which remains in gradual cyclical recovery even as long-term pressures remain.</li>     <li>Arch Coal (<a href='https://seekingalpha.com/symbol/ARCH' title='Arch Coal Inc'>ARCH</a> <font color='red'>-2.1%</font>) is FBR's top stock in the group, given its exposure to both met and thermal prices and its low-cost production profile.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253053\" data-linked=\"Cloud Peak upgraded at FBR; Peabody\u2019s emergence may boost coal valuations\" data-tweet=\"$CLD $CLDPQ $BTU - Cloud Peak upgraded at FBR; Peabody\u2019s emergence may boost coal valuations https://seekingalpha.com/news/3253053-cloud-peak-upgraded-fbr-peabody-s-emergence-may-boost-coal-valuations?source=tweet\" data-url=\"https://seekingalpha.com/news/3253053-cloud-peak-upgraded-fbr-peabody-s-emergence-may-boost-coal-valuations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253052\" data-ts=\"1490279527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253052-natural-gas-futures-pares-gains-post-inventory-draw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas futures pares gains post inventory draw</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>-150 Bcf</strong> vs. -150 Bcf consensus, -53 Bcf last week.</li><li>Futures&nbsp;<font color='green'>+0.43%</font>&nbsp;to $3.025.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3253052\" data-linked=\"Natural gas futures pares gains post inventory draw\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas futures pares gains post inventory draw https://seekingalpha.com/news/3253052-natural-gas-futures-pares-gains-post-inventory-draw?source=tweet\" data-url=\"https://seekingalpha.com/news/3253052-natural-gas-futures-pares-gains-post-inventory-draw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253051\" data-ts=\"1490279118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CS\" target=\"_blank\">CS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253051-credit-suisse-down-3-on-capital-raise-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse down more than 3% on capital raise report</a></h4><ul><li>According to Bloomberg,<a href=\"https://www.streetinsider.com/Equity+Offerings/UPDATE%3A+Credit+Suisse+%28CS%29+Said+to+Consider+Stock+Sale+to+Raise+Over+CHF3B+-+Bloomberg/12699739.html\" target=\"_blank\"> the lender is </a>mulling a CHF3B share sale.</li><li><a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a>&nbsp;<font color='red'>-3.1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3253051\" data-linked=\"Credit Suisse down more than 3% on capital raise report\" data-tweet=\"$CS - Credit Suisse down more than 3% on capital raise report https://seekingalpha.com/news/3253051-credit-suisse-down-3-on-capital-raise-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3253051-credit-suisse-down-3-on-capital-raise-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253050\" data-ts=\"1490279086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHL\" target=\"_blank\">CHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253050-china-mobileminus-3_4-dividend-boost-doesnt-materialize\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Mobile -3.4% as dividend boost doesn&#39;t materialize</a></h4><ul>   <li>China Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a>) is <font color='red'>3.4% lower</font> in U.S. trading after an <a href=\"https://seekingalpha.com/news/3253005-china-mobile-limited-reports-fy-results\" target=\"_blank\">earnings report</a> that featured industry-leading revenue growth but failed to deliver a hoped-for dividend boost.</li>    <li>The company is touting an increased dividend payout ratio (2016 full-year ratio to 46%), enough to offset renminbi devaluation, but leaving forward yield around the 3% range.</li>    <li>EBITDA rose nearly 7% to 256.7B yuan, and basic earnings per share were up just 0.2%.</li>    <li>Revenue growth was 6%, and 6.7% from telecom services (a five-year high).</li>    <li>Mobile customers rose 2.7% to 848.9M; of those, 4G customers rose 71.3% to 535.04M.</li>    <li>Shares closed <font color='red'>down 3.4%</font> in Hong Kong.</li>    <li><a href=\"http://www.chinamobileltd.com/en/media/press/p170323.pdf\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3253050\" data-linked=\"China Mobile -3.4% as dividend boost doesn&#39;t materialize\" data-tweet=\"$CHL - China Mobile -3.4% as dividend boost doesn&#39;t materialize https://seekingalpha.com/news/3253050-china-mobileminus-3_4-dividend-boost-doesnt-materialize?source=tweet\" data-url=\"https://seekingalpha.com/news/3253050-china-mobileminus-3_4-dividend-boost-doesnt-materialize\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253049\" data-ts=\"1490279078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PENN\" target=\"_blank\">PENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253049-penn-national-gaming-rallies-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Penn National Gaming rallies after guidance update</a></h4><ul> <li>Shares of Penn National Gaming (<a href='https://seekingalpha.com/symbol/PENN' title='Penn National Gaming, Inc.'>PENN</a> <font color='green'>+7.4%</font>) race higher after the company sets Q1 guidance ahead of estimates.</li> <li>Penn expects Q1 revenue of $770M to $771M vs. $761M prior and $760M consensus. EBITDA of $222M to $223M is seen vs. $209M consensus.</li><li>Shares are now up 20% YTD.</li> <li>Source: <a href=\"https://seekingalpha.com/pr/16779457-penn-national-gaming-raises-2017-first-quarter-guidance-strong-property-operating-trends\" target=\"_blank\">Press Release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253049\" data-linked=\"Penn National Gaming rallies after guidance update\" data-tweet=\"$PENN - Penn National Gaming rallies after guidance update https://seekingalpha.com/news/3253049-penn-national-gaming-rallies-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3253049-penn-national-gaming-rallies-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253043\" data-ts=\"1490278902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEC\" target=\"_blank\">ATEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253043-alphatec-secures-18_9m-capital-raise-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphatec secures $18.9M capital raise; shares down 15%</a></h4><ul><li>Thinly traded nano cap Alphatec Holdings (<a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='red'>-14.6%</font>) slips on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/16779577-alphatec-holdings-announces-18_9-million-private-placement\" target=\"_blank\">announcement </a>of a private placement of common stock, Series A Convertible Preferred Stock and warrants raising $18.9M in capital. Buyers are healthcare-focused institutional investors, company directors and executives and others. Closing date is March 28.</li><li>The deal includes the sale of 1,809,628 common shares at $2, 15,245 Series A shares (convertible into ~7.6M common shares) and warrants to purchase up to ~9.4M common shares at $2.00.</li><li>Alphatec executives and directors have agreed to buy $2.35M of Series A shares, convertible into ~1.175M common shares and warrants to purchase up to 1.175M common shares at $2.00.</li><li>Yesterday's close was $2.68.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253043\" data-linked=\"Alphatec secures $18.9M capital raise; shares down 15%\" data-tweet=\"$ATEC - Alphatec secures $18.9M capital raise; shares down 15% https://seekingalpha.com/news/3253043-alphatec-secures-18_9m-capital-raise-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3253043-alphatec-secures-18_9m-capital-raise-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253046\" data-ts=\"1490278712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253046-supervalu-spikes-after-glowing-rbc-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SuperValu spikes after glowing RBC call</a></h4><ul> <li>Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) is <font color='green'>up 10.03%</font> after RBC Capital upgrades the grocery store stock to Outperform.</li> <li>\"With easing deflation/eventual inflation, a very strong wholesale win pipeline, and under-appreciated real estate portfolio, we believe SVU is very attractive,\" writes analyst William Kirk.</li> <li>It's not too late to jump on RBC's bull call as the firm's price target of <a href=\"https://www.streetinsider.com/Analyst+Comments/RBC+Capital+Upgrades+SUPERVALU+%28SVU%29+to+Outperform/12698241.html\" target=\"_blank\">$6</a> implies +70% upside potential.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3253046\" data-linked=\"SuperValu spikes after glowing RBC call\" data-tweet=\"$SVU - SuperValu spikes after glowing RBC call https://seekingalpha.com/news/3253046-supervalu-spikes-after-glowing-rbc-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3253046-supervalu-spikes-after-glowing-rbc-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253036\" data-ts=\"1490277927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253036-enrollment-underway-in-atossas-early-stage-study-of-breast-cancer-candidate-endoxifen-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enrollment underway in Atossa&#39;s early-stage study of breast cancer candidate endoxifen; shares continue down move, off 8%</a></h4><ul><li>Thinly traded nano cap Atossa Genetics (<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='red'>-8.3%</font>) has lost almost 36% in a week, a continuation of a multi-year downtrend during which it has lost 97% of its value. Today, it <a href=\"https://seekingalpha.com/pr/16779447-atossa-genetics-opens-enrollment-study-endoxifen\" target=\"_blank\">announced </a>the start of enrollment in a Phase 1 study in Australia assessing the pharmacokinetics of breast cancer candidate endoxifen, an active metabolite of tamoxifen, the active ingredient in Nolvadex, formerly marketed by AstraZeneca (stopped manufacturing in June 2006).</li></ul><div class=\"tiny-share-widget\" data-id=\"3253036\" data-linked=\"Enrollment underway in Atossa&#39;s early-stage study of breast cancer candidate endoxifen; shares continue down move, off 8%\" data-tweet=\"$ATOS - Enrollment underway in Atossa&#39;s early-stage study of breast cancer candidate endoxifen; shares continue down move, off 8% https://seekingalpha.com/news/3253036-enrollment-underway-in-atossas-early-stage-study-of-breast-cancer-candidate-endoxifen-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3253036-enrollment-underway-in-atossas-early-stage-study-of-breast-cancer-candidate-endoxifen-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253035\" data-ts=\"1490276938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253035-five-belowplus-11-organic-growth-remains-on-track\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below +11% as organic growth remains on track</a></h4><ul> <li>Five Below (NASDAQ:<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a>) is <font color='green'>up 10.86%</font> after topping comparable sales (+1.0% vs. +0.9%) and EPS ($0.90 vs. $0.89) estimates by a slim margin.</li> <li>Analysts say the rally is tied to some relief that the retailer didn't lower its guidance like many of its peers.</li> <li>An important point with Five Below is that new stores continue to perform well amid what is almost universally called a \"challenging\" retail environment.</li> <li>Loop Capital (Buy, $54 PT) says Five Below is one of the more compelling long-term organic growth stories in the retail sector. Jefferies (Buy, $55 PT) points to the effectiveness of TV ads as the store base broadens.</li> <li>Sources: CNBC and Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252832-five-beats-0_01-beats-revenue\" target=\"_blank\">Five Below beats by $0.01, beats on revenue</a> (March 22)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3252858-five-6-percent-store-growth-feeds-q4-beat\" target=\"_blank\">Five Below up 6% as store growth feeds Q4 beat</a> (March 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253035\" data-linked=\"Five Below +11% as organic growth remains on track\" data-tweet=\"$FIVE - Five Below +11% as organic growth remains on track https://seekingalpha.com/news/3253035-five-belowplus-11-organic-growth-remains-on-track?source=tweet\" data-url=\"https://seekingalpha.com/news/3253035-five-belowplus-11-organic-growth-remains-on-track\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253029\" data-ts=\"1490276379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHL\" target=\"_blank\">SCHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253029-scholasticminus-2-loss-widens-in-seasonally-weak-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scholastic -2% as loss widens in seasonally weak quarter</a></h4><ul>   <li>Scholastic (NASDAQ:<a href='https://seekingalpha.com/symbol/SCHL' title='Scholastic Corporation'>SCHL</a>) has come out of the open <font color='red'>down 2%</font> after a <a href=\"https://seekingalpha.com/news/3252936-scholastic-misses-0_11-misses-revenue\" target=\"_blank\">fiscal Q3 earnings miss</a> where revenues declined in each segment and losses widened.</li>    <li>The company usually reports a loss in Q3 on lower revenues, but loss per share increased to $0.45 from a year-ago loss of $0.21/share.</li>    <li>It offset some of the revenue drop with planned cost controls.</li>    <li>Revenue by segment: Children's Book Publishing/Distribution, $199M (down 9%); Education, $60.1M (down 6%); International, $77.1M (down 6.3%; down 5% ex-currency).</li>    <li>The company affirmed its 2017 outlook for revenues of $1.7B-$1.8B (vs. consensus for $1.794B) and EPS from continuing operations of $1.60-$1.70 (vs. consensus for $1.70).</li>    <li><a href=\"https://seekingalpha.com/pr/16779179-scholastic-reports-fiscal-2017-third-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3253029\" data-linked=\"Scholastic -2% as loss widens in seasonally weak quarter\" data-tweet=\"$SCHL - Scholastic -2% as loss widens in seasonally weak quarter https://seekingalpha.com/news/3253029-scholasticminus-2-loss-widens-in-seasonally-weak-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3253029-scholasticminus-2-loss-widens-in-seasonally-weak-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253024\" data-ts=\"1490275611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253024-interpace-diagnostics-restructures-debt-in-convertible-stock-and-warrant-deal-shares-ease-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpace Diagnostics restructures debt in convertible stock and warrant deal; shares ease 6% premarket</a></h4><ul><li>Interpace Diagnostics Group (NASDAQ:<a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a>) slips&nbsp;<font color='red'>6%</font>&nbsp;premarket on increased volume in response to the <a href=\"https://seekingalpha.com/pr/16779499-interpace-diagnostics-group-announces-agreements-successfully-restructure-debt-terminate\" target=\"_blank\">deal it struck</a> to restructure its $9.34M debt to RedPath.</li><li>It sold the debt obligation to an unnamed institutional investor for $8.9M. The investor agreed to exchange the debt for a ~$5.32M secured convertible note with a fixed conversion price of $2.44 and a ~$3.55M secured note issued by the company. The notes will bear interest at the Fed funds rate and will mature on June 22, 2018 at 125% of face value.</li><li>In addition, RedPath will receive five-year warrants to purchase up to 100K common shares at $4.69.</li><li>The deal should close today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253024\" data-linked=\"Interpace Diagnostics restructures debt in convertible stock and warrant deal; shares ease 6% premarket\" data-tweet=\"$IDXG - Interpace Diagnostics restructures debt in convertible stock and warrant deal; shares ease 6% premarket https://seekingalpha.com/news/3253024-interpace-diagnostics-restructures-debt-in-convertible-stock-and-warrant-deal-shares-ease-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3253024-interpace-diagnostics-restructures-debt-in-convertible-stock-and-warrant-deal-shares-ease-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253020\" data-ts=\"1490275168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253020-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='red'>-20%</font> on secondary stock offering.</li><li><a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-19%</font> on secondary stock offering.</li><li><a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a> <font color='red'>-11%</font> on secondary stock offering.</li><li><a href='https://seekingalpha.com/symbol/INNL' title='Innocoll'>INNL</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-9%</font> on restructuring debt and terminating royalty obligations.</li><li><a href='https://seekingalpha.com/symbol/OEC' title='Orion Engineered Carbons'>OEC</a> <font color='red'>-8%</font> on secondary stock offering.</li><li><a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='red'>-7%</font> on failure of Phase 2 clinical trial for UX007.</li><li><a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253020\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$HTBX $TNDM $QUIK - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3253020-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3253020-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253018\" data-ts=\"1490275097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253018-ford-sets-disappointing-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford sets disappointing profit guidance</a></h4><ul> <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) says it expects Q1 EPS of $0.30 to $0.35 vs. $0.47 consensus. The weak profit guidance is due in part to higher costs, lower automobile volume and an unfavorable exchange rate environment.</li> <li>The company backs prior guidance for pre-tax profit of $1.5B in 2017.</li> <li><a href=\"https://seekingalpha.com/filing/3471825\" target=\"_blank\">SEC Form 8-K</a></li> <li>Ford&nbsp;<font color='red'>-2.46%</font>&nbsp;premarket to $11.48.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3253018\" data-linked=\"Ford sets disappointing profit guidance\" data-tweet=\"$F - Ford sets disappointing profit guidance https://seekingalpha.com/news/3253018-ford-sets-disappointing-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3253018-ford-sets-disappointing-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>121&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253015\" data-ts=\"1490274822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253015-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+58%</font> on receiving CE Mark certification for genetic lung cancer test.<br></li><li>SSH <font color='green'>+26%</font> on increased utilization in Aquadex business.<br></li><li><a href='https://seekingalpha.com/symbol/DRWI' title='DragonWave Inc.'>DRWI</a> <font color='green'>+19%</font> on Canadian provider contract.</li><li><a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+17%</font> on Q4 earnings.</li><li><a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='green'>+14%</font> on Syndros being placed in Schedule II of the Controlled Substances Act.</li><li><a href='https://seekingalpha.com/symbol/FIVE' title='Five Below'>FIVE</a> <font color='green'>+8%</font> on Q4 earnings.</li><li><a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='green'>+8%</font> on analyst upgrade.</li><li><a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+7%</font> on Q4 earnings.</li><li><a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+7%</font> on FQ2 earnings.</li><li><a href='https://seekingalpha.com/symbol/PENN' title='Penn National Gaming, Inc.'>PENN</a> <font color='green'>+5%</font> on being added to  S&amp;P SmallCap 600 index.<br></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253015\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$HTGM $CHFS $DRWI - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3253015-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3253015-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253014\" data-ts=\"1490274748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253014-tandem-diabetes-prices-stock-offering-1_25-shares-off-19-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) slips&nbsp;<font color='red'>19%</font>&nbsp;premarket on robust volume in response to the <a href=\"https://seekingalpha.com/pr/16779409-tandem-diabetes-care-announces-pricing-underwritten-public-offering-common-stock\" target=\"_blank\">pricing </a>of its public offering of 18M shares of common stock at $1.25 per share. Underwriters over-allotment is an additional 2.7M shares. Closing date is March 28.</li><li>Yesterday's close was $1.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253014\" data-linked=\"Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket\" data-tweet=\"$TNDM - Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket https://seekingalpha.com/news/3253014-tandem-diabetes-prices-stock-offering-1_25-shares-off-19-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3253014-tandem-diabetes-prices-stock-offering-1_25-shares-off-19-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253007\" data-ts=\"1490274458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253007-kroger-shoots-higher-after-rbc-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kroger shoots higher after RBC upgrade</a></h4><ul> <li>RBC sees <a href=\"http://www.cnbc.com/2017/03/23/early-movers-acn-schl-teva-ppg-wfm-feye-shld-wfc-more.html\" target=\"_blank\">upside</a> for Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>) on a call tied to the benefits the grocery store chain should see from broad macro improvements.</li> <li>The investment firm lifts shares of Kroger to Outperform from Sector Perform and assigns a price target of $37.</li> <li>Shares of Kroger are<font color='green'> up 1.69%</font> premarket to $29.45 vs. a 52-week trading range of $28.29 to $39.22.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3253007\" data-linked=\"Kroger shoots higher after RBC upgrade\" data-tweet=\"$KR - Kroger shoots higher after RBC upgrade https://seekingalpha.com/news/3253007-kroger-shoots-higher-after-rbc-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3253007-kroger-shoots-higher-after-rbc-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253008\" data-ts=\"1490274458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253008-sunshine-heart-driving-aquadex-business-shares-up-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunshine Heart driving Aquadex business; shares up 22% premarket</a></h4><ul><li>Thinly traded nano cap Sunshine Heart (SSH) jumps&nbsp;<font color='green'>22%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16779123-sunshine-heart-provides-business-update-regarding-execution-strategic-growth-plan\" target=\"_blank\">update </a>on the <a href=\"https://www.sunshineheart.com/aquapheresis/\" target=\"_blank\">Aquadex</a> business it acquired from Baxter International in August of last year.</li><li>The company says its its revenue growth strategy focused on increased utilization in its top hospital accounts is paying off. At the end of 2016, it had 95 hospital customers buying the disposable blood sets on a regular basis. It now has 115.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253008\" data-linked=\"Sunshine Heart driving Aquadex business; shares up 22% premarket\" data-tweet=\"$CHFS - Sunshine Heart driving Aquadex business; shares up 22% premarket https://seekingalpha.com/news/3253008-sunshine-heart-driving-aquadex-business-shares-up-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3253008-sunshine-heart-driving-aquadex-business-shares-up-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253002\" data-ts=\"1490273918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOLS\" target=\"_blank\">AOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253002-barda-ends-funding-for-development-of-aeolus-pharmas-aeol-10150-for-radiation-exposure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BARDA ends funding for development of Aeolus Pharma&#39;s AEOL 10150 for radiation exposure</a></h4><ul><li>The U.S government's Biomedical Advanced Research and Development Authority &#40;BARDA&#41; <a href=\"https://seekingalpha.com/pr/16779336-aeolus-receives-barda-decision-regarding-additional-options-lung-ars-development-contract\" target=\"_blank\">notifies </a>Aeolus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AOLS' title='Aeolus Pharmaceuticals, Inc.'>OTCPK:AOLS</a>) that it will not exercise its additional options to fund the continued development of AEOL 10150 as a medical countermeasure for pulmonary injury associated with radiation exposure. It has invested over $30M to date under a five-year agreement valued as high as $118M.</li><li>Management is \"stunned\" by the decision and \"vehemently disagrees\" with BARDA's rationale for backing out while questioning the \"integrity\" of the process.</li><li>The company says it will continue developing the product for ideopathic pulmonary fibrosis and cancer.</li><li><a href=\"http://www.aolsrx.com/product-pipeline/aeol-10150\" target=\"_blank\">AEOL 10150</a>&nbsp;is a broad spectrum&nbsp;<a href=\"http://www.sciencedirect.com/science/article/pii/S1359644604031393\" target=\"_blank\">catalytic antioxidant</a>&nbsp;specifically designed to neutralize reactive oxygen and nitrogen species, thereby reducing oxidative stress, inflammation and tissue damage-signaling cascades resulting from radiation exposure.</li><li>Nasdaq does not report any premarket trading but stockholders should expect a substantial down move at the open.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253002\" data-linked=\"BARDA ends funding for development of Aeolus Pharma&#39;s AEOL 10150 for radiation exposure\" data-tweet=\"$AOLS - BARDA ends funding for development of Aeolus Pharma&#39;s AEOL 10150 for radiation exposure https://seekingalpha.com/news/3253002-barda-ends-funding-for-development-of-aeolus-pharmas-aeol-10150-for-radiation-exposure?source=tweet\" data-url=\"https://seekingalpha.com/news/3253002-barda-ends-funding-for-development-of-aeolus-pharmas-aeol-10150-for-radiation-exposure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3253001\" data-ts=\"1490273884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGIX\" target=\"_blank\">CGIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3253001-cancer-genetics-revenues-up-31-in-q4-shares-up-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cancer Genetics revenues up 31% in Q4; shares up 12% premarket</a></h4><ul><li>Cancer Genetics (<a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a>) <a href=\"https://seekingalpha.com/pr/16779239-cancer-genetics-inc-announces-record-revenue-fourth-quarter-full-year-2016-provides-2017\" target=\"_blank\">Q4 results</a>: Revenues: $7.2M (+30.9%); Net Loss: ($2.8M) (+50.9%); Loss Per Share: ($0.15) (+68.8%).</li><li><strong>2016 results</strong>: Revenues: $27M (+50.0%); Net Loss: ($15.8M) (+21.8%); Loss Per Share: ($1.00) (+49.0%); Quick Assets: $9.5M (-51.3%).</li><li>Shares are up&nbsp;<font color='green'>12.1%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3253001\" data-linked=\"Cancer Genetics revenues up 31% in Q4; shares up 12% premarket\" data-tweet=\"$CGIX - Cancer Genetics revenues up 31% in Q4; shares up 12% premarket https://seekingalpha.com/news/3253001-cancer-genetics-revenues-up-31-in-q4-shares-up-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3253001-cancer-genetics-revenues-up-31-in-q4-shares-up-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252989\" data-ts=\"1490272265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252989-tandem-diabetes-files-sminus-1-for-follow-on-stock-offering-shares-slip-23-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes files S-1 for follow-on stock offering; shares slip 23% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) is down&nbsp;<font color='red'>23%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16765997-tandem-diabetes-care-announces-filing-registration-statement-proposed-follow-public-offering\" target=\"_blank\">announcement </a>that it has filed an S-1 in preparation for a $50M equity offering. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252989\" data-linked=\"Tandem Diabetes files S-1 for follow-on stock offering; shares slip 23% premarket\" data-tweet=\"$TNDM - Tandem Diabetes files S-1 for follow-on stock offering; shares slip 23% premarket https://seekingalpha.com/news/3252989-tandem-diabetes-files-sminus-1-for-follow-on-stock-offering-shares-slip-23-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3252989-tandem-diabetes-files-sminus-1-for-follow-on-stock-offering-shares-slip-23-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252987\" data-ts=\"1490272233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252987-fireeyeplus-8_18-pre-market-upgraded-from-sell-to-buy-goldman-sachs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye +8.18% pre-market, upgraded from Sell to Buy at Goldman Sachs</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+FireEye%2C+Inc+%28FEYE%29+to+Buy/12698354.html\" target=\"_blank\">Analyst Gabriela Borges</a> notes product revenue and billings expectations that have been reset, and highlights a quicker-than-anticipated mix shift to recurring revenue and materializing detail on pricing model for&nbsp;<a href=\"https://www.fireeye.com/products/helix.html\" target=\"_blank\">Helix</a>.</li><li>Forecasts improvement in consistency with regard to execution and free cash flow generation.</li><li>Target from $10 to $15. FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) $12.43 pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252987\" data-linked=\"FireEye +8.18% pre-market, upgraded from Sell to Buy at Goldman Sachs\" data-tweet=\"$FEYE - FireEye +8.18% pre-market, upgraded from Sell to Buy at Goldman Sachs https://seekingalpha.com/news/3252987-fireeyeplus-8_18-pre-market-upgraded-from-sell-to-buy-goldman-sachs?source=tweet\" data-url=\"https://seekingalpha.com/news/3252987-fireeyeplus-8_18-pre-market-upgraded-from-sell-to-buy-goldman-sachs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252985\" data-ts=\"1490271966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTBX\" target=\"_blank\">HTBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252985-heat-bio-prices-stock-offering-0_80-shares-down-20-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heat Bio prices stock offering at $0.80; shares down 20% premarket</a></h4><ul><li>Heat Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a>) slumps&nbsp;<font color='red'>20%</font>&nbsp;premarket on robust volume in response to the <a href=\"https://seekingalpha.com/pr/16779312-heat-biologics-prices-offering-5000-000-shares-common-stock\" target=\"_blank\">pricing </a>of its public offering of 5M shares of common stock at $0.80 per share. Underwriters over-allotment is an additional 750K shares. Net proceeds will fund pipeline development, working capital and general corporate purposes. Closing date is March 28.</li><li>Yesterday's close was $1.03.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252985\" data-linked=\"Heat Bio prices stock offering at $0.80; shares down 20% premarket\" data-tweet=\"$HTBX - Heat Bio prices stock offering at $0.80; shares down 20% premarket https://seekingalpha.com/news/3252985-heat-bio-prices-stock-offering-0_80-shares-down-20-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3252985-heat-bio-prices-stock-offering-0_80-shares-down-20-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252983\" data-ts=\"1490271741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252983-la-jolla-pharma-prices-stock-offering-33_50-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La Jolla Pharma prices stock offering at $33.50; shares ahead 2% premarket</a></h4><ul><li>La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a>) <a href=\"https://seekingalpha.com/pr/16779327-la-jolla-pharmaceutical-company-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 3.7M shares of common stock at $33.50. Underwriters over-allotment is an additional 559.7K shares. Closing date is March 28. Net proceeds will be used for general corporate purposes.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li><li>Yesterday's close was $34.11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252983\" data-linked=\"La Jolla Pharma prices stock offering at $33.50; shares ahead 2% premarket\" data-tweet=\"$LJPC - La Jolla Pharma prices stock offering at $33.50; shares ahead 2% premarket https://seekingalpha.com/news/3252983-la-jolla-pharma-prices-stock-offering-33_50-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3252983-la-jolla-pharma-prices-stock-offering-33_50-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252981\" data-ts=\"1490271168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252981-on-conagra-foods-fq3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on ConAgra Foods&#39; FQ3</a></h4><ul>     <li>ConAgra Foods (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a>) reports net sales declined 4.8% in <a href=\"https://seekingalpha.com/pr/16779234-conagra-brands-reports-continued-margin-expansion-eps-growth-third-quarter\" target=\"_blank\">FQ3</a> primarily as a result of volume declines associated with the Company's actions to build a higher quality revenue base.</li>     <li>Segment net sales:&nbsp;Grocery &amp; Snacks: $849.8M (-5.4%);&nbsp;Refrigerated &amp; Frozen: $666.4M (-6%);&nbsp;International: $205.2M (-3%);&nbsp;Foodservice: $259.8M (-2.6%).</li>     <li>Gross margin rate grew 180 bps to 31.6%.</li>     <li>SG&amp;A expense rate improved 260 bps to 17.7%.</li>     <li><b>FY2017 Guidance</b>: Net sales: Slightly below the low-end of the range of down 4% to 5% (excluding the impacts of divestitures and foreign exchange); Adjusted gross margin rate: 30.4% to 30.6%; Adjusted operating margin rate: Slightly above the range of 15.3% to 15.5%; Adjusted EPS: At or slightly above the high-end of the $1.65 to $1.70 range.</li>     <li>CAG&nbsp;<font color='red'>-0.69%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3252981\" data-linked=\"More on ConAgra Foods&#39; FQ3\" data-tweet=\"$CAG - More on ConAgra Foods&#39; FQ3 https://seekingalpha.com/news/3252981-on-conagra-foods-fq3?source=tweet\" data-url=\"https://seekingalpha.com/news/3252981-on-conagra-foods-fq3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252970\" data-ts=\"1490270597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FI\" target=\"_blank\">FI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252970-franks-internationalminus-5-following-stock-sale-mosing-family\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frank&#39;s International -5% following stock sale by Mosing family</a></h4><ul>     <li>Frank's International (NYSE:<a href='https://seekingalpha.com/symbol/FI' title='Frank&#39;s International'>FI</a>) <font color='red'>-4.8%</font> premarket after <a href=\"https://seekingalpha.com/pr/16779126-frank-s-international-n-v-confirms-sale-common-stock-certain-members-mosing-family-related\" target=\"_blank\">confirming a sale</a> by certain members of the Mosing family and  related family members of ~5.6M shares to Morgan Stanley.</li>     <li>Following the sale, members of Mosing family and affiliated entities will own a ~75% interest in the company.</li>     <li>FI notes that the company is not offering any stock in the transaction and will not receive any proceeds from sale of shares by family members.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252970\" data-linked=\"Frank&#39;s International -5% following stock sale by Mosing family\" data-tweet=\"$FI - Frank&#39;s International -5% following stock sale by Mosing family https://seekingalpha.com/news/3252970-franks-internationalminus-5-following-stock-sale-mosing-family?source=tweet\" data-url=\"https://seekingalpha.com/news/3252970-franks-internationalminus-5-following-stock-sale-mosing-family\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252941\" data-ts=\"1490267805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUIK\" target=\"_blank\">QUIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252941-quiklogic-down-nearly-11-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QuikLogic down nearly 11% on capital raise</a></h4><ul><li>The company <a href=\"https://seekingalpha.com/pr/16779192-quicklogic-corporation-announces-pricing-15_0-million-public-offering-common-stock\" target=\"_blank\">priced a 10M share sale</a> at $1.50 each. Underwriter Craig-Hallum has an option to buy up to another 1.5M shares at that price.</li><li><a href='https://seekingalpha.com/symbol/QUIK' title='QuickLogic Corporation'>QUIK</a>&nbsp;<font color='red'>-10.6%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3252941\" data-linked=\"QuikLogic down nearly 11% on capital raise\" data-tweet=\"$QUIK - QuikLogic down nearly 11% on capital raise https://seekingalpha.com/news/3252941-quiklogic-down-nearly-11-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3252941-quiklogic-down-nearly-11-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3252934\" data-ts=\"1490266997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3252934-egalet-nabs-four-patents-covering-abuse-deterrent-technology-shares-ahead-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Egalet nabs four patents covering abuse-deterrent technology; shares ahead 5% premarket</a></h4><ul><li>Egalet (<a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16779144-egalet-announces-issuance-new-u-s-international-patents-guardian-technology\" target=\"_blank\">announcement </a>that it has been awarded four patents covering its abuse-deterrent Guardian technology.</li><li>In the U.S., the USPTO has issued Patent No. 9,549,899 covering pain med ARYMO ER (morphine sulfate) extended-release tablets for oral use only.</li><li>Europe patent # 2393487, Australia patent #2015200243 and Canada patent #2,751,667 cover Guardian technology, Canada's Guardian's immediate-release system designed to slow the release of the active pharmaceutical ingredient in the presence of alcohol.</li><li>The patents are in effect until 2030 - 2033.</li></ul><div class=\"tiny-share-widget\" data-id=\"3252934\" data-linked=\"Egalet nabs four patents covering abuse-deterrent technology; shares ahead 5% premarket\" data-tweet=\"$EGLT $ZCOR - Egalet nabs four patents covering abuse-deterrent technology; shares ahead 5% premarket https://seekingalpha.com/news/3252934-egalet-nabs-four-patents-covering-abuse-deterrent-technology-shares-ahead-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3252934-egalet-nabs-four-patents-covering-abuse-deterrent-technology-shares-ahead-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":61,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}